Home/ Author / The Inside Investor
    Sort By
  • Newest

  • Newest

  • Oldest

  • Author Name

  • Author Name

  • David Chaplin

  • Drew Meredith

  • Giselle Roux

  • Greg Bright

  • Ishan Dan

  • James Dunn

  • Lachlan Maddock

  • Owen Raszkiewicz

  • All Categories

  • All Categories

  • Uncategorized

  • IN Discussion

  • TO BE RECATEGORIZED

  • Leaders

  • Opinion

  • News

  • Daily Market Update

  • Investing 101

  • SMSFs

  • ASX

  • Investing

The Inside Investor

The Inside Investor results

ASX down 0.5%, reporting season peaks

ASX down 0.5%, reporting season peaks, Coles (ASX:COL), Woolworths (ASX:WOW) sold off The ASX200 (ASX:XJO) fell 0.5% on what was one of the busiest days of reporting season, with 20 companies releasing either half-year or quarterly updates. The consumer staples sector was the biggest detractor, falling 3.5% on fears that recent trends will slow, with the property sector…

The Inside Investor | 17th Feb 2021 | More
Biotech BARD1 cancer detection treatment gaining traction

BARD1 Life Sciences (ASX: BD1) – Earlier in the week, the Inside Investor team published an article on BARD1 Life Sciences (click here) and its meteoric rise following a positive announcement on ovarian cancer detection. Shares have risen from 74.5c on the day of the announcement to $3.20 at the time of writing. That’s a…

Ishan Dan | 17th Feb 2021 | More
‘When the product is free, you are the product’

There has been a lot written about the GameStop saga in the last few weeks. I want to discuss the medium-term market impacts rather than moralising about who is right and wrong. While I doubt it marks the top of the current market, there are some concerning signs. Quick background  The wallstreetbets forum on Reddit spawned several short…

Damien Klassen | 17th Feb 2021 | More
Managed fund fees continue to fall

Despite their popularity in the institutional world, managed funds remain one of the most misunderstood investments by DIY investors. Thus far fund managers have done little to improve the education of end investors to the benefits of their ‘unit trust’ structure. The underlying premise of a managed fund is simple, to pool the capital of…

Drew Meredith | 17th Feb 2021 | More
Nearmap (ASX: NEA) defends a short-selling attack

Last week, Beijing based short-selling activist firm J Capital launched a scathing report on Australian aerial imagery technology firm (and small cap darling) Nearmap (ASX: NEA), in the hope that it would trigger a sell-off so that it could profit handsomely from short positions in the company. The report titled “Afraid to Admit Failure” attacked…

Ishan Dan | 17th Feb 2021 | More
  • Hume gives SMSFs a big tick of approval

    Unlike their counterparts at the big end of town, the trustees of SMSFs were given a glowing endorsement by Senator Jane Hume, the assistant minister for superannuation, at the SMSF Association annual conference this week. Her conference speech on the first day of the two-day virtual event (February 16) probably would have drawn rapturous applause…

    Greg Bright | 17th Feb 2021 | More
    Our Authors
    Popular